Agile Therapeutics, Inc. Proceeds from Warrant Exercises
Agile Therapeutics, Inc. reported Proceeds from Warrant Exercises of $4.38 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2024-08-12
- Agile Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2024-06-30 was $0.00.
- Agile Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2024-03-31 was $4.38M.
| Period end | Proceeds from Warrant Exercises | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month |
|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $4.38M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $4.38M 10-Q · filed 2024-05-15 | ||
| 2023-06-30 | $6.51M 10-Q · filed 2024-08-12 | ||
| 2020-02-10 | $20.00M 10-Q · filed 2024-08-12 |